Position in IQV
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$2,511
+$806 QoQ
Shares Held
13
+30.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#97
of 107 holders
Holding Since
Mar 2022
6 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in IQV Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Marquette Asset Management, LLC holds $687,930 across 12 Diagnostics & Research names. IQV ranks #8 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | FLGT |
Fulgent Genetics, Inc.
|
30,269 | $621,119 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
45 | $22,561 | |
| 3 | A |
Agilent Technologies, Inc.
|
87 | $11,556 | |
| 4 | NTRA |
Natera, Inc.
|
28 | $7,600 | |
| 5 | DHR |
Danaher Corp /De/
|
38 | $7,238 | |
| 6 | IDXX |
Idexx Laboratories Inc /De
|
13 | $6,843 | |
| 7 | MTD |
Mettler Toledo International Inc/
|
2 | $2,555 | |
| 8 | IQV |
Iqvia Holdings Inc.
This page
|
13 | $2,511 |
All Filings in IQV
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,511 | 13 | Shares | Sole | 2026-07-09 | |
| 2026-03-31 | $1,705 | 10 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $2,254 | 10 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $1,899 | 10 | Shares | Sole | 2025-10-24 | |
| 2022-06-30 | $433 | 2 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $462 | 2 | Shares | Sole | 2022-04-26 | |
| No filing history on record for this holder in this stock. | ||||||